XML 64 R57.htm IDEA: XBRL DOCUMENT v3.25.2
Stock-Based Compensation - Summary of Stock Incentive Plans Activity (Detail)
6 Months Ended
Jul. 12, 2025
$ / shares
shares
Restricted Stock Awards [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Outstanding, Beginning balance | shares 325,228
Granted | shares 0
Vested | shares (210,378)
Cancelled/Forfeited | shares (15,023)
Outstanding, Ending balance | shares 99,827
Weighted Average Grant-Date Fair Value, Beginning balance | $ / shares $ 27.32
Weighted Average Grant-Date Fair Value, Granted | $ / shares 0
Weighted Average Grant-Date Fair Value, Vested | $ / shares 27.52
Weighted Average Grant-Date Fair Value, Cancelled/Forfeited | $ / shares 27
Weighted Average Grant-Date Fair Value, Ending balance | $ / shares $ 26.93
Restricted Stock Units [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Outstanding, Beginning balance | shares 563,471
Granted | shares 637,132
Vested | shares (213,464)
Cancelled/Forfeited | shares (130,143)
Outstanding, Ending balance | shares 856,996
Weighted Average Grant-Date Fair Value, Beginning balance | $ / shares $ 20.27
Weighted Average Grant-Date Fair Value, Granted | $ / shares 19.57
Weighted Average Grant-Date Fair Value, Vested | $ / shares 20.32
Weighted Average Grant-Date Fair Value, Cancelled/Forfeited | $ / shares 19.74
Weighted Average Grant-Date Fair Value, Ending balance | $ / shares $ 19.82
Performance Share Units [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Outstanding, Beginning balance | shares 678,565
Granted | shares 490,887
Vested | shares 0
Cancelled/Forfeited | shares (134,604)
Outstanding, Ending balance | shares 1,034,848
Weighted Average Grant-Date Fair Value, Beginning balance | $ / shares $ 23.18
Weighted Average Grant-Date Fair Value, Granted | $ / shares 19.52
Weighted Average Grant-Date Fair Value, Vested | $ / shares 0
Weighted Average Grant-Date Fair Value, Cancelled/Forfeited | $ / shares 21.37
Weighted Average Grant-Date Fair Value, Ending balance | $ / shares $ 21.68